COMPANIES COVERED
AmgenDownload FREE Report Sample
Download Free sampleCancer immunotherapy?(sometimes called immuno-oncology) is the use of the?immune system?to treat?cancer.
Immuno-oncology Therapy Market contains market size and forecasts of Immuno-oncology Therapy in Global, including the following market information:
Global Immuno-oncology Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immuno-oncology Therapy market was valued at 1268.7 million in 2021 and is projected to reach US$ 1704.3 million by 2028, at a CAGR of 4.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immuno-oncology Therapy include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche, GlaxoSmithKline, Janssen Biotech, Merck and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immuno-oncology Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-oncology Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immuno-oncology Therapy Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Global Immuno-oncology Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immuno-oncology Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Center
Others
Global Immuno-oncology Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immuno-oncology Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-oncology Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immuno-oncology Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co., Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
